pamidronate has been researched along with Hepatocellular Carcinoma in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"This study presents 3 cases of refractory pain from bone metastases due to thyroid, colorectal and hepatocellular carcinoma." | 1.32 | [Bisphosphonate as an adjuvant therapy for the pain of bone metastases, 3 cases]. ( Hattori, S; Kudo, K; Miyakawa, H; Noguchi, T; Okuda, K, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hattori, S | 1 |
Miyakawa, H | 1 |
Okuda, K | 1 |
Kudo, K | 1 |
Noguchi, T | 1 |
Wada, A | 1 |
Fukui, K | 1 |
Sawai, Y | 1 |
Imanaka, K | 1 |
Kiso, S | 1 |
Tamura, S | 1 |
Shimomura, I | 1 |
Hayashi, N | 1 |
2 other studies available for pamidronate and Hepatocellular Carcinoma
Article | Year |
---|---|
[Bisphosphonate as an adjuvant therapy for the pain of bone metastases, 3 cases].
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Diphosphonates; Female; Hum | 2004 |
Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movemen | 2006 |